IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $283,718 | +36.4% | 46,435 | +936.3% | 0.02% | +240.0% |
| Q4 2020 | $208,000 | -35.6% | 4,481 | -54.3% | 0.01% | -68.8% |
| Q3 2020 | $323,000 | +0.9% | 9,806 | -15.9% | 0.02% | -11.1% |
| Q2 2020 | $320,000 | +32.2% | 11,658 | +43.9% | 0.02% | +12.5% |
| Q1 2020 | $242,000 | -40.8% | 8,099 | -45.2% | 0.02% | 0.0% |
| Q4 2019 | $409,000 | +53.2% | 14,768 | +0.5% | 0.02% | +33.3% |
| Q3 2019 | $267,000 | +8800.0% | 14,693 | +9083.1% | 0.01% | – |
| Q2 2019 | $3,000 | -95.2% | 160 | -97.1% | 0.00% | -100.0% |
| Q3 2018 | $62,000 | -55.7% | 5,500 | -50.0% | 0.00% | -50.0% |
| Q2 2018 | $140,000 | -38.6% | 11,000 | -18.5% | 0.01% | -52.9% |
| Q1 2018 | $228,000 | +185.0% | 13,500 | +35.0% | 0.02% | +183.3% |
| Q4 2017 | $80,000 | +37.9% | 10,000 | +33.3% | 0.01% | +20.0% |
| Q3 2017 | $58,000 | -80.1% | 7,500 | -81.0% | 0.01% | -82.1% |
| Q2 2017 | $291,000 | – | 39,534 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |